Peh Chao Xu, Liu Jianlin, Bishop George D, Chan Hui Yu, Chua Shi Min, Kua Ee Heok, Mahendran Rathi
Department of Psychological Medicine, National University Health System, Singapore.
Yale-NUS College, Singapore.
Psychooncology. 2017 Aug;26(8):1191-1197. doi: 10.1002/pon.4297. Epub 2016 Oct 24.
A proportion of newly diagnosed cancer patients may experience anxiety and depression. Emotion suppression has been associated with poorer psychoemotional outcomes, whereas reappraisal may be an adaptive emotion regulation strategy. Few studies have examined potential mechanisms linking reappraisal to psychoemotional outcomes in cancer patients. This study aims to replicate findings on reappraisal and suppression and further examines if hope mediates the association between reappraisal and anxiety/depression in patients newly diagnosed with cancer.
Participants were 144 adult cancer patients (65.3% female, mean age = 48.96 years, SD = 9.23). Patients completed a set of study questionnaires, including the Emotion Regulation Questionnaire, Adult Hope Scale, and the Hospital Anxiety and Depression Scale. Path analysis was used to examine if hope mediated the association between reappraisal and anxiety/depression.
Prevalence of anxiety was 39.6% and depression was 25.0%. Reappraisal and hope were correlated with lower anxiety and depression, whereas suppression was correlated with higher anxiety and depression. The hypothesized mediation model provided fit to the data, comparative fit index = 0.95, Tucker-Lewis index = 0.94, root-mean-square-error of approximation = 0.05. There was a significant indirect effect of reappraisal on anxiety and depression via hope, b = -0.95, SE = 0.42, 95% confidence interval = -1.77 to -0.12, whereas the direct effect of reappraisal was nonsignificant.
The study findings suggest that hope mediated the association between reappraisal and anxiety/depression outcomes. Moreover, the high prevalence of anxiety and depression implies a need for healthcare providers to attend to the psychoemotional needs of newly diagnosed cancer patients.
一部分新诊断的癌症患者可能会经历焦虑和抑郁。情绪抑制与较差的心理情绪结果相关，而重新评价可能是一种适应性情绪调节策略。很少有研究探讨将重新评价与癌症患者心理情绪结果联系起来的潜在机制。本研究旨在重复关于重新评价和抑制的研究结果，并进一步检验希望是否在新诊断癌症患者中调节重新评价与焦虑/抑郁之间的关联。
参与者为144名成年癌症患者（65.3%为女性，平均年龄 = 48.96岁，标准差 = 9.23）。患者完成了一组研究问卷，包括情绪调节问卷、成人希望量表和医院焦虑抑郁量表。路径分析用于检验希望是否调节重新评价与焦虑/抑郁之间的关联。
焦虑患病率为39.6%，抑郁患病率为25.0%。重新评价和希望与较低的焦虑和抑郁相关，而抑制与较高的焦虑和抑郁相关。假设的中介模型与数据拟合良好，比较拟合指数 = 0.95，塔克 - 刘易斯指数 = 0.94，近似均方根误差 = 0.05。重新评价通过希望对焦虑和抑郁有显著的间接效应，b = -0.95，标准误 = 0.42，95%置信区间 = -1.77至 -0.12，而重新评价的直接效应不显著。
研究结果表明希望在重新评价与焦虑/抑郁结果之间起中介作用。此外，焦虑和抑郁的高患病率意味着医疗保健提供者需要关注新诊断癌症患者的心理情绪需求。
